Common symptoms of lung cancer

Lung cancer may have no obvious symptoms in the early stages, but as the disease progresses, patients may develop the following symptoms:

• Persistent cough: The cough does not go away, or the original cough gets worse.

• Hemoptysis: There are blood streaks in the sputum, or blood-colored sputum is coughed up.

• Chest Pain: Discomfort or pain in the chest, especially when taking deep breaths, coughing, or laughing.

• Difficulty breathing: Feeling short of breath, wheezing, or having chest tightness.

• Tiredness and Weakness: A noticeable feeling of fatigue that usually does not improve with rest.

• Weight Loss: Unexplained weight loss accompanied by loss of appetite.

• Recurrent colds or lung infections: Frequent infections that require repeated treatment.

• Hoarseness: The voice becomes hoarse or changes.

• Fingertip deformation: There may be “mallet fingers” or rounded nails.

Focus of lung cancer drug treatment

1. Lung cancer target drugs

• Definition: Targeting specific genes in cancer cells in order to reduce damage to normal cells.

• Category: Including EGFR target drugs, ALK and ROS1 inhibitors, and anti-angiogenic drugs.

• Applicable objects: Mainly targeted at patients with non-small cell lung cancer, especially those who are EGFR positive.

• Side Effects: Possible constipation, diarrhea, fatigue, as well as rash and nausea that may be caused by EGFR drugs.

2. Lung cancer immunotherapy drugs

• Definition: Fighting cancer cells by activating the body’s immune system.

• Category: Including PD-1/PD-L1 inhibitors and CTLA-4 inhibitors.

• Applicable objects: Can be used as first-line treatment, and PD-L1 testing is required to determine suitability.

• Side effects: Usually mild, with fatigue, fever, and nausea being common.

3. Lung cancer chemotherapy drugs

• Definition: Treating cancer by destroying rapidly growing cells.

• Category: Including platinum compounds, antimetabolites, vinca alkaloids, paclitaxel, etc.

• Applicable objects: Widely applicable to all types of lung cancer, including non-small cell lung cancer.

• Side effects: May affect the blood, gastrointestinal tract and skin, with common anemia, nausea, vomiting, etc.

4. List of commonly used drugs

• Target drugs:

• EGFR: Osimertinib, Afatinib, Dacomitinib, Gefitinib, Erlotinib

• ALK/ROS1: Alectinib, Ceritinib, Crizotinib

• Anti-vascular proliferation: Ramucirumab, Bevacizumab

• Immunotherapy:

• PD-1/PD-L1: Pembrolizumab, Nivolumab, Atezolizumab

• CTLA-4: Ipilimumab

• Chemotherapy drugs:

• Platinum: Cisplatin, Carboplatin

• Antimetabolite: Pemetrexed, Gemcitabine

• Vinorelbine: Vinorelbine

• Paclitaxel: Docetaxel, Paclitaxel

How to use the testing toolRGCC TEST Find out the most strong>Treatment modalities withpotentialthat canbe effective

Lung cancer patients may need to try different drugs and treatments, which may bring unnecessary toxic burden. To address this issue, personalized treatment can tailor the best treatment plan to the patient’s specific situation, thereby reducing the toxic burden and improving treatment efficacy. Comprehensive and accurate testing tools, such as the Onconomics Plus test, can provide critical information for personalized treatment.

• CTC Number: This test provides a number of circulating tumor cells (CTCs) through a simple blood test. The increase or decrease in CTC values ​​can guide the treatment effect and help develop more effective treatment strategies.

• Cancer cell gene expression: This test can reveal how a cancer cell’s genes adapt to and resist treatment, helping to quickly develop more effective treatments program, before cancer cells become drug-resistant provide patients with the most effective treatment.

• The effect of chemotherapy drugs, targeted drugs and natural substances on cancer cells: This test analyzes more than 50 chemotherapy drugs and 60 targets The effects of drugs and more than 50 natural substances on cancer cells, determining which drugs are most effective for a patient’s cancer type and taking the guesswork out of treatment.

The Onconomics Plus test provides this critical information to help patients and clinicians find the most effective treatment options. The test is particularly useful for patients who are preparing to start treatment, who wish to evaluate the effectiveness of their current treatment, and patients who feel that their treatment options are limited. By utilizing this information, clinicians can develop more targeted treatment plans for patients, improving efficacy and reducing unnecessary side effects.

Medical Disclaimer:

The information provided in this article is for educational and informational purposes only and does not constitute medical advice and should not be used as a substitute for professional medical diagnosis, treatment or advice . Always consult your physician or other qualified health professional with any questions you may have regarding your medical condition or medical problems. The content of this article is not intended to recommend any specific test, treatment, or medication and should not be considered such advice. If you develop symptoms or need medical assistance, please contact a medical professional promptly.